|
2019
|
Invention
|
Therapeutic cancer vaccine. The present invention relates to vaccine(s) comprising cancer cells e... |
|
2017
|
Invention
|
Pharmaceutical composition of killed cells with substantially retained immunogenicity.
The prese... |
|
2016
|
G/S
|
Pharmaceutical preparations for human use namely pharmaceutical preparations for the treatment an... |
|
2015
|
Invention
|
Mycobacterium w. Mycobacterium w can also be used along with other therapeutic agent(s)/modalitie... |
|
2014
|
Invention
|
Indole 3-carbinol derivatives. The present invention relates to novel stable indole-3-carbinol de... |
|
|
Invention
|
Indole-3-carbinol derivatives. The present invention relates to novel stable indole-3-carbinol de... |
|
|
Invention
|
A process for the preparation of 6-fluoro-3,4-dihydro-2h-chromene- 2-carbaldehyde. The present in... |
|
2013
|
Invention
|
Process for the preparation of bosentan. The present invention relates to a process for the prepa... |
|
2012
|
Invention
|
Cancer antigen. Mycobacterium w or combination there of shows altered protein profile. Thus alter... |
|
|
Invention
|
Cancer antigen. Cancer cells when treated with cisplatin, paclitaxel, gemcitabine, Mycobacterium ... |
|
|
Invention
|
P38 inhibitors.
The invention relates to novel p38 MAPK inhibitor which involves Mycobacterium w... |
|
|
Invention
|
Therapeutic cancer vaccine.
The present invention relates to vaccine(s) comprising cancer cells ... |
|
|
Invention
|
Pharmaceutical composition for treating cancer.
The present invention relates to increase in sur... |
|
|
Invention
|
Mycobacterium w for use in treating cancer. The present invention relates to increase in survival... |
|
|
Invention
|
Pharmaceutical composition for treating cancer. The present invention relates to increase in surv... |
|
2011
|
Invention
|
Process for the preparation of agomelatine. The present invention relates to a process for the ma... |
|
|
Invention
|
Process for preparation of clevidipine and its intermediate. The present invention relates to a p... |
|
|
Invention
|
Pharmaceutical composition of taxoids. The present invention relates to a stable oral pharmaceuti... |
|
|
Invention
|
Pharmaceutical composition of taxoids. The present invention relates to the stable oral pharmaceu... |
|
|
Invention
|
Vaccine adjuvants. Mycobacterium w and antigen containing composition. e.g. immune naïve or preim... |
|
|
Invention
|
Pharmaceutical compositions of curcumin. The present invention relates to stable liquid pharmaceu... |
|
|
Invention
|
Novel compounds as dpp-iv inhibitors and process for preparation thereof. The present invention r... |
|
|
Invention
|
Process for the conversion of (2r)-6-fluoro-2-[(2s)-oxiran-2-yl]-3,4-dihydro-2h-chromene to (2r)-... |
|
|
Invention
|
Hypoglycemic compounds. The present invention relates to novel hypoglycemic compounds of formula ... |
|
|
Invention
|
Novel hypoglycemic compounds. The present invention relates to novel hypoglycemic compounds of fo... |
|
|
Invention
|
An improved process for the preparation of amorphous atorvastatin calcium. The present invention ... |
|
|
Invention
|
Pharmaceutical composition of killed cells with substantially retained immunogenicity. This inven... |
|
|
Invention
|
A pharmaceutical composition of killed cells with substantially retained immunogenicity. This inv... |
|
2010
|
Invention
|
Pharmaceutical composition of isoniazid. The present invention relates to pharmaceutical composit... |
|
|
Invention
|
Pharmaceutical composition of rifampicin. The present invention relates to a pharmaceutical compo... |
|
|
Invention
|
Hypolipaemic pharmaceutical compositions. The present invention related to hypolipaemic pharmaceu... |
|
|
Invention
|
Stable pharmaceutical composition for atherosclerosis. The present invention relates to a stable ... |
|
|
Invention
|
Stable pharmaceutical composition for atherosclerosis. The present invention relates to a s... |
|
|
Invention
|
An improved process for the preparation of paliperidone. The invention relates to an improved pro... |
|
|
Invention
|
Novel process for preparing pure 6-fluoro-3-piperidin-4-yl-1,2-benzisoxazole hydrochloride and it... |
|
|
Invention
|
Preparation of 3-(2-hydroxy ethyl)-9-hydroxy-2-methyl-4h-pyrido-[1,2-a]-pyrimidin-4-one or its ac... |
|
2009
|
Invention
|
Process of synthesis of paliperidone. The invention relates to an improved process for preparatio... |
|
|
Invention
|
Farnesoid-x-receptor antagonist as a vaccine adjuvant. The invention provides novel adjuvants and... |
|
|
Invention
|
Dipeptidyl peptidase iv (dp-iv) compounds. The present invention is directed to novel compounds o... |
|
2008
|
Invention
|
Stable solutions of sparingly soluble actives.
The present invention relates to a stable pharmac... |
|
|
Invention
|
Mitogen activated protein kinase modulator.
The present invention describes the method of modula... |
|
2007
|
Invention
|
Process for preparing amorphous atorvastatin hemi calcium salt and its itermediate.
The inventio... |
